跳至主要内容
临床试验/NCT00461942
NCT00461942已完成2 期

A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study to Assess the Neuroprotection Effect of Green Tea Polyphenol in De Novo Parkinson's Disease Patients

Xuanwu Hospital, Beijing2 个研究点 分布在 1 个国家目标入组 480 人开始时间: 2006年4月最近更新:
适应症
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
480
试验地点
2
主要终点
Delay of progression of Motor dysfunction

研究概览

简要总结

The purpose of this study is to determine whether Green Tea Polyphenol, an extraction from Green Tea is effective and safe in the treatment of De Novo Parkinson's disease Patients without taking any antiparkinsonism drug

详细描述

The primary outcome measurement is UPDRS using a delay start design. Total 480 de novo PD patients divided into three dosage groups of green tea polyphenol and one placebo control group. Patients will be treated for one year.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Double

入排标准

年龄范围
30 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Willing and able to give informed consent
  • Age 30 years or older at time of diagnosis of Parkinson's disease
  • Diagnosed as having typical PD
  • Parkinson's disease duration of no more than 5 years
  • No current dopaminergic or other forms of anti-parkinsonism therapy
  • Hoehn and Yahr stage < 3

排除标准

  • 未提供

结局指标

主要结局

Delay of progression of Motor dysfunction

次要结局

  • Quality of Daily life
  • Mood;
  • Cognition;

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验